An Overview of NCI’s National
Clinical Trials Network
On March 1, 2014, after several years of extensive consultation and coordination with many stakeholders, NCI transformed its longstanding Cooperative Group program into the new National Clinical Trials Network (NCTN). Guided by recommendations in a 2010 Institute of Medicine (IOM) report, the design and implementation of the NCTN incorporates feedback from Cooperative Group investigators, NCI Comprehensive Cancer Center directors, several NCI working groups, leading cancer researchers, industry representatives, and patient advocates. For a detailed review of the new NCTN and its goals please click here.
Links to Funding Opportunity Announcements for NCTN Program are below:
|NCTN Program Key Component||Funding Opportunity
|Network Group Operations Centers||RFA-CA-12-010 (U10)|
|Network Group Statistics & Data Management Centers||RFA-CA-12-011 (U10)|
|Network Group Integrated Translational Science Centers||RFA-CA-12-012 (U10)|
|Network Lead Academic Participating Sites||RFA-CA-12-013 (U10)|
|Network Radiotherapy & Imaging Core Services Centers||RFA-CA-12-014 (U24)|
|Canadian Collaborating Clinical Trials Network||RFA-CA-12-504
(Limited Competition U10)
- DCTD is collaborating with the Center for Cancer Genomics on the Clinical Trial Sequencing Project (CTSP) to promote the use of genomics in NCI-sponsored clinical trials of the NCTN. Read the March 2015 announcement of the CTSP to NCTN Network Groups.
- Frequently Asked Questions — December 15, 2012 for NCTN Program (PDF)
- Contact NCI/DCTD by email at: NCTNProgram@mail.nih.gov with any questions.
- NCI Cooperative Group Program Archive